Navigation Links
Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
Date:1/6/2012

SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 30th Annual J. P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California.   

The corporate presentation will review the Company accomplishments in 2011, as well as outline the corporate plans for 2012 and beyond.

Specifically, the Company will discuss the recent very productive Type C meeting that was held with the FDA on elagolix for endometriosis, one of the outcomes of which was the decision to file a Special Protocol Assessment (SPA) with the FDA. The expected NDA filing of elagolix for the treatment of endometriosis is in 2015.

Additionally, the presentation will cover the Company's VMAT2 program for movement disorders, including the status of the current Phase II study assessing the impact of NBI-98854 in patients with tardive dyskinesia. This study, which began in the fall of 2011, has recently completed enrollment and will report top-line data in the first quarter of 2012.  The Company also recently received a notification of allowable claims for its NBI-98854 European Patent Application from the European Patent Office, and has begun planning for larger Phase IIb trials, to be launched in mid-2012, for up to three months of continuous treatment with NBI-98854.

 

The live presentation takes place on Thursday, January 12, 2012 at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  A copy of the presentation materials will be filed with the Securities and Exchange Commission on or before Monday, January 9, 2012.

If you
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
2. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
4. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
5. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
6. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
7. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
8. Neurocrine Biosciences To Present at the Stifel Nicolaus 2011 Healthcare Conference
9. Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
10. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
11. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- IBM Watson Health (NYSE: IBM ) today announced ... leading cancer institutes to accelerate the ability of clinicians ... The institutes will apply Watson,s ... the ability to translate DNA insights, understand a person,s ... to personalize treatment options. The project is part of ...
(Date:5/5/2015)... 5, 2015 (Family Features) Which health screenings ... like most adults, monitoring your weight, cholesterol, and blood ... But what about vision care? Photo ... reach their 40s, they often start to notice small ... lives and job performance. Whether having difficulty reading a ...
(Date:5/5/2015)... and NIJMEGEN, the Netherlands ... medical device company developing lower esophageal sphincter (LES) ... long-term, 3-year, positive safety and efficacy results. The ... of both heartburn and regurgitation and the "gold-standard" ... test) with near-complete elimination of dependence on daily ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Eye Care as You Age 2Eye Care as You Age 3Eye Care as You Age 4Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... CEO Yaacov Shoham today issued the following statement, ... and asked them to upgrade IDenta,s current tier. They are ... 1. Annual financial report (audited) for year 2011 ( ... Statement The files can be found at the ...
... Mass., April 26, 2012  Sensitech Inc., the global ... the International Air Transport Association (IATA) has deemed ... devices to be in compliance with the 53rd ... Provision (SP) 188 published by the United Nations.   ...
Cached Medicine Technology:International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets. 2Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA 2
(Date:5/5/2015)... Scottsdale, AZ (PRWEB) May 05, 2015 ... NCPDP’s Elite Partner Program. The program establishes a three-year ... to a maximum of 10 Elite Partners. “AmerisourceBergen has ... Ann Stember, President of NCPDP, “and this is a ... work. , We can trace AmerisourceBergen back to ...
(Date:5/5/2015)... York, NY (PRWEB) May 05, 2015 ... Health IVF Clinic in Greece, an experienced team ... and treatment of infertility for patients around the globe. ... partnered with VisitandCare.com. Greece unquestionably remains a global leader ... most talented and hard-working fertility specialists in the world ...
(Date:5/5/2015)... York (PRWEB) May 05, 2015 ... http://www.testosteronelawsuithub.com/ ) filed on behalf of men ... to their use of prescription testosterone replacement ... federal multidistrict litigation underway in U.S. District ... court documents dated May 1st, defendants AbbVie, ...
(Date:5/5/2015)... Baptist Medical Center Jacksonville’s cancer program ... of the American College of Surgeons. , To earn ... than 30 Commission on Cancer quality care standards, be ... maintain levels of excellence in the delivery of comprehensive ... seek care locally at a CoC-accredited cancer center, they ...
(Date:5/5/2015)... Skedans Systems a division of ... Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems ... developers, provides tooling to deliver real time information for ... Skedans Sensor Collaboration Platform is a single unified cloud ... Things, Web Real Time Communications (WebRTC), and commercial Unmanned ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 2Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 3Health News:Baptist Medical Center Jacksonville Receives National Cancer Reaccreditation 4Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2
... SHANGHAI, China, Oct. 5 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: ... Chinese firm,specializing in the manufacture, research, development, marketing ... of its,previously announced underwritten public offering. The Company ... per share in its public offering,resulting in approximately ...
... is estimated that more than 7,000 people are diagnosed with ... approximately 3,500 cases result in death. These cancers include ... some have been linked to the sexually transmitted infection, HPV-16. ... 90 cancerous tissue samples to look for genes that indicated ...
... the University of Santiago de Compostela (USC) has established that ... soft drinks are far higher than those indicated on their ... to a new technique developed by the researchers to determine ... Ascorbic acid or vitamin C is a ...
... Trapeze Networks, a Belden Brand (NYSE: BDC ... the goal of extending the company,s leadership in the ... focused on three strategies: It will increase the ... clinics and residential care facilities, help Trapeze Networks, cadre ...
... (ARI) states that many diagnosed with autism have underlying ... parents, researchers, and clinicians from around the world will ... ARI/Defeat Autism Now! Conference in Dallas, TX. , ... published results from a 2007 telephone survey in ...
... ... "Boost Your Juice Contest" in October, in which healthcare and wellness businesses can participate ... campaign worth up to $5,000. , ... Phoenix, AZ (PRWEB) October 5, 2009 -- As confusion reigns in ...
Cached Medicine News:Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 3Health News:DNA test could be key to targeting treatments for head and neck cancer 2Health News:Fruit juices contain more vitamin C than their labels indicate 2Health News:Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market 2Health News:New Government Research Finds One in Every 100 Children Has Autism, of Whom Nearly 40% Are Recovered 2Health News:Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 2Health News:Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: